Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides
EDMONTON, Alberta, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic …